Vimarsana
Biggest News Aggregation in the World

Page 20 - Priya Singhal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Priya Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Priya Singhal Today - Breaking & Trending Today

Biogen (NASDAQ:BIIB) Cut to "Equal Weight" at Wells Fargo & Company - Vimarsana News

Biogen (NASDAQ:BIIB) Cut to "Equal Weight" at Wells Fargo & Company

Wells Fargo & Company cut shares of Biogen (NASDAQ:BIIB – Free Report) from an overweight rating to an equal weight rating in a report issued on Wednesday morning, MarketBeat Ratings reports. The brokerage currently has $240.00 price objective on the biotechnology company’s stock, down from their previous price objective of $315.00. A number of other […]

Biogen (NASDAQ:BIIB) PT Lowered to $325.00 at Piper Sandler - Vimarsana News

Biogen (NASDAQ:BIIB) PT Lowered to $325.00 at Piper Sandler

Biogen (NASDAQ:BIIB – Free Report) had its price target reduced by Piper Sandler from $350.00 to $325.00 in a research report released on Wednesday, Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. A number of other research firms also recently commented on BIIB. BTIG Research reiterated a neutral rating on […]

Source: wkrb13.com
Oppenheimer Trims Biogen (NASDAQ:BIIB) Target Price to $290.00 - Vimarsana News

Oppenheimer Trims Biogen (NASDAQ:BIIB) Target Price to $290.00

Biogen (NASDAQ:BIIB – Free Report) had its price target reduced by Oppenheimer from $295.00 to $290.00 in a research report released on Wednesday, Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. Several other equities analysts also recently weighed in on the company. Bank Of America (Bofa) dropped their price objective […]

Biogen (NASDAQ:BIIB) PT Lowered to $300.00 at Needham & Company LLC - Vimarsana News

Biogen (NASDAQ:BIIB) PT Lowered to $300.00 at Needham & Company LLC

Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by Needham & Company LLC from $305.00 to $300.00 in a research report released on Tuesday, MarketBeat reports. Needham & Company LLC currently has a buy rating on the biotechnology company’s stock. Other equities research analysts have also issued reports about the stock. Wells Fargo […]

Source: wkrb13.com
Biogen (NASDAQ:BIIB) Price Target Lowered to $325.00 at Piper Sandler - Vimarsana News

Biogen (NASDAQ:BIIB) Price Target Lowered to $325.00 at Piper Sandler

Biogen (NASDAQ:BIIB – Free Report) had its price objective cut by Piper Sandler from $350.00 to $325.00 in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. BIIB has been the topic of a number of other reports. BTIG Research reaffirmed a […]